Buyer's Guide
Country:
Zipcode:
Operation:
Search for:
Companies Products Countries ZIP Code (Germany) New Companies
0-9   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z

Contact | Print version | PDF version | Recommend company

Allon Therapeutics Inc.
506–1168 Hamilton Street
V6B 2S2 Vancouver, BC
Canada

Phone:  +16047360634
Fax:  +16047361616

Contact / Request Information

Portrait
Allon Therapeutics Inc. is a clinical-stage biotechnology company developing treatments for major neurodegenerative conditions. In Q1 2008, Allon’s drug AL-108 demonstrated human efficacy in amnestic mild cognitive impairment, a precursor to Alzheimer’s disease. Allon has Phase II human efficacy programs pursuing three large underserved markets: Alzheimer's disease, stroke and schizophrenia-related cognitive impairment. The Company is based in Vancouver.

Industrial Sectors
  • Pharmacy

       
      Additional information

      Allon Therapeutics Inc.
      Vancouver, BC, Canada

      News
      - 27 May 2008 - Allon completes dosing in Phase II cognitive impairment trial
      - 05 Oct 2007 - Allon Therapeutics completes enrolment for Phase II Alzheimer's trial
      - 17 Sep 2007 - Allon commences Phase II schizophrenia trial and updates clinical progress
       more news
      MyBionity.COM
      Newsletter Subscription
      Your e-mail:
      Top  
      © 2001-2008 Chemie.DE Information Service GmbH
      a Life Science Network Division

       www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET